TTrialPathMatch Me to Trials
← Back to trials
RecruitingDry Eye

Long-term Effects of Acoltremon vs. Control in Dry Eye Disease

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a prospective, longitudinal, single-center study designed to evaluate the long-term changes in symptoms and tear production in subjects with dry eye disease. The study is randomized and investigator-masked, with subjects assigned to either the TRYPTYR (Acoltremon ophthalmic solution 0.003%) arm or the control arm (Refresh Classic Preservative-free). The study will be conducted at a single site, with subjects undergoing assessments at baseline and at months 1, 3, 6, 9, and 12.

Sponsor: The Eye Care Institute

You may qualify if…

  • ✓ 1. Male or female, 18 years of age or older at the Screening visit.
  • ✓ 2. Have a previous history of DED, clinician diagnosed, or patient reported, within the previous 6 months prior to the Screening visit.
  • ✓ 3. Have used, and/or desired to use artificial tears for DED symptoms within 2 months prior to the Screening visit.
  • ✓ 4. Both of the following signs of DED in the same eye:
  • ✓ 1. Total corneal fluorescein staining score of \>= 2 and \<= 10 based on the NEI grading scheme, with no one region scoring \> 3 in at least 1 eye.
  • ✓ 2. Unanesthetized Schirmer test score \>= 2 and \< 10 mm/5 min in at least 1 eye.
  • ✓ 3. If both eyes qualify, the eye with the lower baseline Schirmer score will be the study eye (If the Schirmer score is the same, the right eye will be the study eye).
  • ✓ 5. Symptomatic defined as an ODS-VAS score of \>=40.

You may not qualify if…

  • ✕ 1. History or presence of any ocular disorder or condition (other than DED) in either eye that would, in the opinion of the investigator, interfere with the interpretation of the study results or subject safety.
  • ✕ 2. Diagnosis of recurrent, ongoing, or active ocular infection.
  • ✕ 3. History of ocular surgery within 1 year prior to the Screening visit.
  • ✕ 4. Have had a corneal transplant in either or both eyes.
  • ✕ 5. Use of contact lenses within 2 hours of any study visit.
  • ✕ 6. Use of lid heating therapy or Meibomian gland probing/therapeutic expression within 1 year prior to the Screening visit.
  • ✕ 7. Use of artificial tears within 24 hours of Screening visit.
  • ✕ 8. Use of any topical ocular anti-inflammatory medication or dry eye pharmaceuticals within 30 days prior to the Screening visit.

Where it's recruiting

Kentucky

Louisville

Source: ClinicalTrials.gov · NCT07659626 · last updated 2026-08-20